{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:45:28Z","timestamp":1788975928427,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018712","name":"Universitatea de Medicina si Farmacie Iuliu Hatieganu Biologice celulara si moleculara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijcard.2024.132659","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T17:56:21Z","timestamp":1729274181000},"page":"132659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unlocking the potential of biomarkers: The promise of adrenomedullin and its precursors in diagnosing and assessing heart failure"],"prefix":"10.1016","volume":"418","author":[{"given":"Robert Cristian","family":"Cruciat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi","family":"Gazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Ismaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel-Corneliu","family":"Leucuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahlah","family":"Al Srouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan-Lucian","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ismaiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Ensar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan L.","family":"Dumitrascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132659_bb0005","series-title":"Congestive Heart Failure","author":"Malik","year":"2023"},{"issue":"20","key":"10.1016\/j.ijcard.2024.132659_bb0010","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcard.2024.132659_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014240","article-title":"Clinical implications of the New York heart association classification","volume":"8","author":"Caraballo","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132659_bb0020","first-page":"1161","article-title":"Diagnosis and evaluation of heart failure","volume":"85","author":"King","year":"2012","journal-title":"Am. Fam. Physician"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ejhf.1366","article-title":"Adrenomedullin in heart failure: pathophysiology and therapeutic application","volume":"21","author":"Voors","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.ijcard.2024.132659_bb0030","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1172\/JCI118680","article-title":"Cardiac secretion of adrenomedullin in human heart failure","volume":"97","author":"Jougasaki","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030524","article-title":"Mid-regional Proadrenomedullin as a new biomarker of kidney and cardiovascular diseases-is it the future?","volume":"10","author":"Czajkowska","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132659_bb0040","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2024.132659_bb0045","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in meta-Analyses Ottawa, Ontario, Canada","author":"Wells","year":"2021"},{"key":"10.1016\/j.ijcard.2024.132659_bb0050","series-title":"The Ottawa Hospital Ohrica","author":"Wells","year":"2021"},{"issue":"5","key":"10.1016\/j.ijcard.2024.132659_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users: R as a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J. Stat. Softw."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.ijcard.2024.132659_bb0065","author":"Love"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.92.3.286","article-title":"Elevation of circulating and ventricular adrenomedullin in human congestive heart failure","volume":"92","author":"Jougasaki","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcard.2024.132659_bb0075","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/0735-1097(95)00338-X","article-title":"Increased plasma levels of adrenomedullin in patients with heart failure","volume":"26","author":"Nishikimi","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2024.132659_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2169\/internalmedicine.34.728","article-title":"Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects","volume":"34","author":"Tanaka","year":"1995","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132659_bb0085","first-page":"180","article-title":"Plasma adrenomedullin concentration in patients with heart failure","volume":"81","author":"Kato","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132659_bb0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0002-8703(96)90270-7","article-title":"Increased plasma adrenomedullin in acute myocardial infarction","volume":"131","author":"Kobayashi","year":"1996","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132659_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/cs0920059","article-title":"Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders","volume":"92","author":"Cheung","year":"1997","journal-title":"Clin. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0008-6363(97)00164-8","article-title":"Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C- natriuretic prohormone peptides compared as early heart failure indicators","volume":"36","author":"Daggubati","year":"1997","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132659_bb0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/hrt.79.1.39","article-title":"Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity","volume":"79","author":"Miyao","year":"1998","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/clc.4960220211","article-title":"Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels","volume":"22","author":"Etoh","year":"1999","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0115","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1677\/joe.0.1600297","article-title":"Molecular forms of circulating adrenomeduilin in patients with congestive heart failure","volume":"160","author":"Hirayama","year":"1999","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0120","first-page":"155","article-title":"Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction","volume":"86","author":"Yu","year":"2001","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132659_bb0125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinbiochem.2003.09.007","article-title":"Development of an ultrasensitive enzyme immunoassay for human proadrenomedullin N-terminal 20 peptide and direct measurement of two molecular forms of PAMP in plasma from healthy subjects and patients with cardiovascular disease","volume":"37","author":"Hashida","year":"2004","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132659_bb0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2169\/internalmedicine.43.1015","article-title":"Evaluation of neurohumoral activation (adrenomedullin, BNP, catecholamines, etc.) in patients with acute myocardial infarction","volume":"43","author":"Katayama","year":"2004","journal-title":"Intern. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/clc.4960290309","article-title":"Plasma adrenomedullin relation with Doppler-derived dP\/dt in patients with congestive heart failure","volume":"29","author":"Morales","year":"2006","journal-title":"Clin. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132659_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/eurjhf\/hfp004","article-title":"Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients","volume":"11","author":"Adlbrecht","year":"2009","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132659_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00011-008-8184-5","article-title":"Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure","volume":"58","author":"Gombos","year":"2009","journal-title":"Inflamm. Res."},{"issue":"17","key":"10.1016\/j.ijcard.2024.132659_bb0150","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehs136","article-title":"Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea","volume":"33","author":"Shah","year":"2012","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132659_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2048872614541904","article-title":"Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department","volume":"4","author":"Bahrmann","year":"2015","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"10.1016\/j.ijcard.2024.132659_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.peptides.2015.12.003","article-title":"Plasma levels of intermedin (adrenomedullin-2) in healthy human volunteers and patients with heart failure","volume":"76","author":"Bell","year":"2016","journal-title":"Peptides"},{"issue":"6","key":"10.1016\/j.ijcard.2024.132659_bb0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00392-016-1066-x","article-title":"Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients","volume":"106","author":"Sinning","year":"2017","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0170","first-page":"184","article-title":"The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure","volume":"17","author":"Y\u0131ld\u0131r\u0131m","year":"2017","journal-title":"Anatol. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132659_bb0175","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00125-018-4727-7","article-title":"Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study","volume":"61","author":"Fraty","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ijcard.2024.132659_bb0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcha.2019.02.011","article-title":"Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome","volume":"22","author":"Arrigo","year":"2019","journal-title":"IJC Heart Vasc."},{"issue":"45","key":"10.1016\/j.ijcard.2024.132659_bb0185","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/eurheartj\/ehz626","article-title":"The neurohormonal basis of pulmonary hypertension in heart failure with preserved ejection fraction","volume":"40","author":"Obokata","year":"2019","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0190","first-page":"487","article-title":"Assessment of mr-proadm and n-terminal b-type natriuretic peptide of serum levels in patients with heart failure","volume":"20","author":"Dahy","year":"2020","journal-title":"Med. Legal Update"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132659_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09674845.2021.1883257","article-title":"Cardiac biomarkers for risk stratification of arrhythmic death in patients with heart failure and reduced ejection fraction","volume":"78","author":"Burger","year":"2021","journal-title":"Br. J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132659_bb0200","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1002\/ehf2.14018","article-title":"Bioactive adrenomedullin for assessment of venous congestion in heart failure","volume":"9","author":"Egerstedt","year":"2022","journal-title":"ESC Heart Fail."},{"issue":"660","key":"10.1016\/j.ijcard.2024.132659_bb0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3399\/bjgp17X691553","article-title":"Practical guidance on heart failure diagnosis and management in primary care: recent EPCCS recommendations","volume":"67","author":"Taylor","year":"2017","journal-title":"Br. J. Gen. Pract."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132659_bb0210","first-page":"1564","article-title":"Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?","volume":"16","author":"Ozturk","year":"2011","journal-title":"J. Res. Med. Sci."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132659_bb0215","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","article-title":"Biomarkers and diagnostics in heart failure","volume":"1832","author":"Gaggin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132659_bb0220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejheart.2005.01.022","article-title":"The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study","volume":"7","author":"Zaphiriou","year":"2005","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132659_bb0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ehf2.12150","article-title":"Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patients","volume":"4","author":"Darche","year":"2017","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ijcard.2024.132659_bb0230","first-page":"9","article-title":"A critical evaluation in the delivery of the ultrasound practice: the point of view of the radiologist","author":"Stasi","year":"2015","journal-title":"Ital. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324012816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324012816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T21:13:15Z","timestamp":1737580395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324012816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"alternative-id":["S0167527324012816"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132659","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the potential of biomarkers: The promise of adrenomedullin and its precursors in diagnosing and assessing heart failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132659"}}